SlideShare une entreprise Scribd logo
1  sur  43
-Omar Ali Saad Mansour
-01151234525
-For any assignment or presentation
No fees
Definition
Hepatitis B is an infectious disease caused
by the hepatitis b virus (HBV) which affects
the liver. It can cause both acute and chronic
infection . Many people have no symptoms
during the initial infection.
The virus is transmitted by exposure to
infectious blood or body fluids. infection around
the time of birth or from contact with other
people's blood during childhood is the most
frequent method by which hepatitis B is
acquired in areas where the disease is common.
In areas where the disease is rare, IV drug
use and sexual intercourse are the most
frequent routes of infection.
High Moderate
Low/Not
Detectable
blood semen urine
serum vaginal fluid feces
wound exudates saliva sweat
tears
breastmilk
Concentration of Hepatitis B Virus
in Various Body Fluids
Signs and Symptoms
ranging from mild to severe, usually appear about one
to four months after you've been infected Signs and
symptoms of hepatitis B may include:
- Abdominal pain - Dark urine
- Fever - Joint pain
- Loss of appetite - Nausea and vomiting
- Weakness and fatigue
- Yellowing of your skin and the whites of your eyes
(jaundice)
Causes
Hepatitis B infection is caused by the hepatitis B virus
(HBV). The virus is passed from person to person
through blood, semen or other body fluids.
Common ways HBV is transmitted include:
Sexual contact. You may become infected if you
have unprotected sex with an infected partner
whose blood, saliva, semen or vaginal
secretions enter your body.
Sharing of needles. HBV is easily transmitted through
needles and syringes contaminated with infected blood.
Sharing intravenous (IV) drug paraphernalia puts you at high
risk of hepatitis B.
Accidental needle sticks. Hepatitis B is a concern for
health care workers and anyone else who comes in contact
with human blood.
Mother to child. Pregnant women infected with HBV can
pass the virus to their babies during childbirth. However, the
newborn can be vaccinated to avoid getting infected in
almost all cases. Talk to your doctor about being tested for
hepatitis B if you are pregnant or want to become pregnant.
Mechanism
The virus mainly affects liver function. It invades the
liver cells (hepatocytes) and uses the cells’ machinery
to replicate within it. The hepatitis B virion binds to the
hepatocyte via the preS domain of the viral surface
antigen. The cell then engulfs the virus in a process
called endocytosis.
As the infection occurs, the host immune response is
triggered. The body’s immune system attacks the
infected hepatocytes, which leads to liver injury at the
same time as clearing the virus from the body.
The liver damage associated with HBV
infection is mainly caused by the adaptive
immune response, particularly the virus-
specific cytotoxic T lymphocytes (CTLs).
These CTLs kill cells that contain the virus.
Liver damage is also aggravated by the
antigen-nonspecific inflammatory cells and
activated platelets at the site of infection.
Acute vs. chronic hepatitis B
Hepatitis B infection may be either short-lived (acute) or
long lasting (chronic).
Acute hepatitis B infection
lasts less than six months. Your immune system
likely can clear acute hepatitis B from your body,
and you should recover completely within a few
months. Most people who acquire hepatitis B as
adults have an acute infection, but it can lead to
chronic infection.
Chronic hepatitis B infection
lasts six months or longer. When your immune system
can't fight off the acute infection, hepatitis B infection
may last a lifetime, possibly leading to serious illnesses
such as cirrhosis and liver cancer.
The younger you are when you get hepatitis B —
particularly newborns or children younger than 5 — the
higher your risk the infection becoming chronic.
Chronic infection may go undetected for decades until a
person becomes seriously ill from liver disease.
Investigation
A- serology :
1- HBsAg
2- antibody to HBsAg ( anti-HBs )
3- HBcAg
4- antibody to HBcAg ( anti-HBc )
5- HBeAg
B- viral load :
* HBV-DNA can be measured by PCR
In the blood .
* Measurement of viral load is
important in monitoring antiviral therapy .
Prevention and precautions of
HBV
prevention
- Hepatitis B vaccine can prevent hepatitis B.
- It is the first anti-cancer vaccine because it can
prevent a form of liver cancer
(hepatocarcinoma).
Who should get hepatitis B vaccine
and when?
- Everyone 18 years of age and younger
- Adults over 18 who are at risk
Adults who are at risk for HBV
infection
- Household contacts of persons with chronic HBV
infection
- Sex contacts of infected people
- People who have more than one sex partner in 6
months
- People who inject illegal drugs
- Heath care and public safety workers who might be
exposed to infected blood or body fluids
- Hemodialysis patients
doses of hepatitis B vaccine
* Infant whose mother is infected with HBV:
- First Dose: within 12 hours of birth
- Second Dose: 1 - 2 months of age
- Third Dose: 6 months of age
* Infant whose mother is NOT infected with HBV:
- First Dose: between birth – 2 months of age
- Second Dose: 1 - 4 months of age
(at least 1 month after first dose)
- Third Dose: 6 - 18 months of age
(at least 2 months after the second dose)
Emergency hepatitis B vaccination
- In some situations, you may also need to
have an injection of antibodies called specific
hepatitis B immunoglobulin (HBIG) along with
the hepatitis B vaccine.
- HBIG should ideally be given within 48 hours,
but you can still have it up to a week after
exposure.
Risks of hepatitis B vaccine
- Severe allergic reactions, harm or death
(extremely rare)
- Soreness at site of injection lasting 1-2 days
- Mild to moderate fever
What if there is a moderate or severe
reaction?
What is an allergic reaction?
- Hives, swelling, redness
- High fever
- Difficulty breathing, wheezing
- Dizziness
- Unusual behavior
When to expect an allergic reaction?
- Within a few minutes to a few hours after the shot
What should I do?
- CALL a doctor or see a doctor right away
- TELL your doctor what happened, and when the vaccination was given
precautions
- A common set of infection-control strategies
should be effective for preventing hepatitis B.
MEDICAL HISTORY:
Always obtain a thorough medical history.
Include specific questions about medications,
current illnesses, hepatitis.
PROTECTIVE ATTIRE AND BARRIER
TECHNIQUES
For protection of personnel and patients:
1-when touching blood, saliva, or mucous membranes . Gloves must be worn
when touching blood-soiled items, body fluids, or secretions, as well as surfaces
contaminated with them. Gloves must be worn when examining all oral lesions.
2. Surgical masks and protective eyewear or face shields must be worn when
splashing or spattering of blood or other body fluids is likely, as is common in
dentistry.
3. Reusable or disposable gowns, laboratory coats, or uniforms must be worn
when clothing is likely to be soiled with blood or other body fluids.
4. Impervious-backed paper or clear plastic wrap may be used to cover surfaces
that may be contaminated by blood or saliva and that are difficult or impossible to
disinfect. The coverings should be removed and replaced between patients.
5. All procedures and manipulations of potentially infective materials should be
performed carefully to minimize the formation of droplets, spatters, and aerosols
such as rubber dams.
Hand washing
Hands must always be washed between patient
treatment contacts (following removal of gloves).
CARE OF SHARP INSTRUMENTS AND
NEEDLES
1-Sharp items (needles, scalpel blades, and other sharp
instruments)
should be considered as potentially infective and must be
handled with extraordinary care to prevent unintentional
injuries.
2. Disposable syringes and needles, scalpel blades, and other
sharp items must be placed into puncture-resistant containers
.
3. Recapping of a needle increases the risk of unintentional
needlestick injury. One hand scope technique should be used .
4. A new (sterile) syringe and a fresh solution should be used
for each patient.
Epidemiology
* Worldwide, HBV is the primary cause of
liver cancer.
- For males, it is the third leading cause of cancer
mortality
- For females, it is the sixth leading cause of
cancer mortality
- An estimated 800,000–1.4 million persons in the
United States have chronic HBV infection.
- Chronic infection is an even greater problem globally,
affecting approximately 350 million persons.
- An estimated 620,000 persons worldwide die from
HBV-related liver disease each year.
Hepatitis B
-The incubation period from the time of exposure
to onset of symptoms is 6 weeks to 6
months.
- HBV is found in highest concentrations in blood
and in lower concentrations in other body fluids
(e.g., semen, vaginal secretions, and wound
exudates).
- HBV infection can be self-limited or chronic.
Hepatitis B
Hepatitis B
In adults, only approximately half of newly
acquired HBV infections are symptomatic, and
approximately 1% of reported cases result in
acute liver failure and death.
Symptomatic Infection
Chronic Infection
Age at Infection
Chronic Infection (%)
SymptomaticInfection(%)
Birth 1-6 months 7-12 months 1-4 years Older Children
and Adults
0
20
40
60
80
100100
80
60
40
20
0
Outcome of Hepatitis B Virus Infection
by Age at Infection
ChronicInfection(%)
Possible Outcomes of HBV Infection
Acute hepatitis B infection
Chronic HBV infection
3-5% of adult-acquired
infections
95% of infant-
acquired infections
Cirrhosis
Chronic hepatitis
12-25% in 5 years
Liver failureHepatocellular
carcinoma
Liver transplant
6-15% in 5 years 20-23% in 5 years
DeathDeath
Complications
Scarring of the liver (cirrhosis). The inflammation
associated with a hepatitis B infection can lead to extensive
liver scarring (cirrhosis), which may impair the liver's ability
to function.
Liver cancer. People with chronic hepatitis B infection have
an increased risk of liver cancer.
Liver failure. Acute liver failure is a condition in which the
vital functions of the liver shut down. When that occurs, a
liver transplant is necessary to sustain life.
Other conditions. People with chronic hepatitis B may have
kidney disease, inflammation of blood vessels or anemia.
Treatment and Drugs
Treatment to prevent hepatitis B infection after
exposure
If you know you've been exposed to the hepatitis B virus,
call your doctor immediately. If you haven't been
vaccinated or aren't sure whether you've been
vaccinated or whether you responded to the vaccination,
receiving an injection of hepatitis B immune globulin
within 12 hours of coming in contact with the virus may
help protect you from developing hepatitis B. You should
be vaccinated at the same time.
Treatment for acute hepatitis B infection
If your doctor determines your hepatitis B
infection is acute — meaning it is short-lived
and will go away on its own — you may not
need treatment. Instead, your doctor might
recommend rest and adequate nutrition and
fluids while your body fights the infection.
If you've been diagnosed with chronic hepatitis B
infection, you may have treatment to reduce the
risk of liver disease and prevent you from passing
the infection to others. Treatments include:
Antiviral medications.
Several antiviral medications — including lamivudine
(Epivir), adefovir (Hepsera), telbivudine (Tyzeka) and
entecavir (Baraclude) — can help fight the virus and slow
its ability to damage your liver. Talk to your doctor about
which medication might be right for you.
Treatment for chronic hepatitis B infection
Interferon alfa-2b (Intron A).
This synthetic version of a substance produced by the
body to fight infection is used mainly for young people
with hepatitis B who don't want to undergo long-term
treatment or who might want to get pregnant within a
few years. It's given by injection. Side effects may include
depression, difficulty breathing and chest tightness.
Liver transplant.
If your liver has been severely damaged, a liver transplant
may be an option. During a liver transplant, the surgeon
removes your damaged liver and replaces it with a
healthy liver. Most transplanted livers come from
deceased donors, though a small number come from
living donors who donate a portion of their livers.
Other drugs to treat hepatitis B are being developed.
HBV (hepatitis B virus )

Contenu connexe

Tendances (20)

Measles
MeaslesMeasles
Measles
 
Viral Hepatitis B, D
Viral Hepatitis B, DViral Hepatitis B, D
Viral Hepatitis B, D
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Epidemiology, prevention and control of viral hepatitis B
Epidemiology, prevention and control of viral hepatitis BEpidemiology, prevention and control of viral hepatitis B
Epidemiology, prevention and control of viral hepatitis B
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
hepatitis B virus
hepatitis B virus hepatitis B virus
hepatitis B virus
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis A, B, and C its management and treatment
Hepatitis A, B, and C its management and treatmentHepatitis A, B, and C its management and treatment
Hepatitis A, B, and C its management and treatment
 
Hepatitis viruses
Hepatitis virusesHepatitis viruses
Hepatitis viruses
 
Hepatitis virus
Hepatitis virusHepatitis virus
Hepatitis virus
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Hepatitis B virus
Hepatitis B virusHepatitis B virus
Hepatitis B virus
 
Hepatitis b infection (hbv)
Hepatitis b infection (hbv)Hepatitis b infection (hbv)
Hepatitis b infection (hbv)
 
Poliomyelitis
PoliomyelitisPoliomyelitis
Poliomyelitis
 
Poliomyelitis
PoliomyelitisPoliomyelitis
Poliomyelitis
 
PNEUMONIA
PNEUMONIAPNEUMONIA
PNEUMONIA
 
MEASLES
MEASLESMEASLES
MEASLES
 

En vedette

En vedette (20)

Hepatitis B virus
Hepatitis B  virusHepatitis B  virus
Hepatitis B virus
 
Hepatitis b virus (hbv)
Hepatitis b virus (hbv)Hepatitis b virus (hbv)
Hepatitis b virus (hbv)
 
Hepatitis B Virus
Hepatitis B VirusHepatitis B Virus
Hepatitis B Virus
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
 
Management of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised PatientsManagement of Viral Hepatitis in Immunocompromised Patients
Management of Viral Hepatitis in Immunocompromised Patients
 
Hepatitis B virus Infection
Hepatitis B virus InfectionHepatitis B virus Infection
Hepatitis B virus Infection
 
Hepatitis b virus in haemodialysis patients. mostafa abdel salam mohamed, muh
Hepatitis b virus in haemodialysis patients. mostafa  abdel salam mohamed, muhHepatitis b virus in haemodialysis patients. mostafa  abdel salam mohamed, muh
Hepatitis b virus in haemodialysis patients. mostafa abdel salam mohamed, muh
 
Hepatitis b package rs mehta
Hepatitis b package rs mehtaHepatitis b package rs mehta
Hepatitis b package rs mehta
 
Hepatitis b virus (hbv) infection a silent epidemic
Hepatitis b virus (hbv) infection a silent epidemicHepatitis b virus (hbv) infection a silent epidemic
Hepatitis b virus (hbv) infection a silent epidemic
 
Hepatitis b
Hepatitis bHepatitis b
Hepatitis b
 
Chronic HEP B
Chronic HEP BChronic HEP B
Chronic HEP B
 
Chronic hepatitis
Chronic hepatitisChronic hepatitis
Chronic hepatitis
 
Hepatitis E
Hepatitis EHepatitis E
Hepatitis E
 
laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)laboratory diagnosis of viral hepatitis (B & C)
laboratory diagnosis of viral hepatitis (B & C)
 
what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)what is Hepatitis B Virus ( HBV)
what is Hepatitis B Virus ( HBV)
 
Pathology of Hepatitis - Lecture
Pathology of Hepatitis - LecturePathology of Hepatitis - Lecture
Pathology of Hepatitis - Lecture
 
Hepatitis B
Hepatitis BHepatitis B
Hepatitis B
 
Hepatitis b
Hepatitis b Hepatitis b
Hepatitis b
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 

Similaire à HBV (hepatitis B virus )

post-exposure-prophylaxis-class 1
post-exposure-prophylaxis-class 1post-exposure-prophylaxis-class 1
post-exposure-prophylaxis-class 1contentmgmcri
 
Bloodborne Pathogens
Bloodborne PathogensBloodborne Pathogens
Bloodborne PathogensRichard Owens
 
Assignment of research.docx
Assignment of research.docxAssignment of research.docx
Assignment of research.docxSamafalechannel
 
Phc hepatitis, son
Phc hepatitis, sonPhc hepatitis, son
Phc hepatitis, sonzarah_son
 
Hepatitis and it's Management slide.pptx
 Hepatitis and it's Management slide.pptx Hepatitis and it's Management slide.pptx
Hepatitis and it's Management slide.pptxjoshuvaganasekaran
 
Hepatitis B.pptx
Hepatitis B.pptxHepatitis B.pptx
Hepatitis B.pptxrehab927665
 
Hepatitis b vaccine
Hepatitis b vaccineHepatitis b vaccine
Hepatitis b vaccinekimhour002
 
Viral hepatitis B and C
Viral hepatitis B and CViral hepatitis B and C
Viral hepatitis B and CD.A.B.M
 
dysfunction of Liver system in body and the nursing intervention to the patient
dysfunction of Liver system in body and the nursing intervention to the patientdysfunction of Liver system in body and the nursing intervention to the patient
dysfunction of Liver system in body and the nursing intervention to the patientdewis24
 
Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1NimzingLadep
 
Hepatitis B Department of Physiotherapy, SHUATS
Hepatitis B Department of Physiotherapy, SHUATSHepatitis B Department of Physiotherapy, SHUATS
Hepatitis B Department of Physiotherapy, SHUATSSurabhi Srivastava
 
HIV HEP C STD and Infectious Disease Training
HIV HEP C  STD and Infectious Disease TrainingHIV HEP C  STD and Infectious Disease Training
HIV HEP C STD and Infectious Disease TrainingMikeLifshotz
 
Viral hepatitis.pptx
Viral hepatitis.pptxViral hepatitis.pptx
Viral hepatitis.pptxAkhilThomas74
 

Similaire à HBV (hepatitis B virus ) (20)

post-exposure-prophylaxis-class 1
post-exposure-prophylaxis-class 1post-exposure-prophylaxis-class 1
post-exposure-prophylaxis-class 1
 
Bloodborne Pathogens
Bloodborne PathogensBloodborne Pathogens
Bloodborne Pathogens
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseases
 
Hepatitis C virus
Hepatitis C virus Hepatitis C virus
Hepatitis C virus
 
Assignment of research.docx
Assignment of research.docxAssignment of research.docx
Assignment of research.docx
 
Phc hepatitis, son
Phc hepatitis, sonPhc hepatitis, son
Phc hepatitis, son
 
Hepatitis and it's Management slide.pptx
 Hepatitis and it's Management slide.pptx Hepatitis and it's Management slide.pptx
Hepatitis and it's Management slide.pptx
 
Aids
AidsAids
Aids
 
Hepatitis B.pptx
Hepatitis B.pptxHepatitis B.pptx
Hepatitis B.pptx
 
Hepatitis b vaccine
Hepatitis b vaccineHepatitis b vaccine
Hepatitis b vaccine
 
Viral hepatitis B and C
Viral hepatitis B and CViral hepatitis B and C
Viral hepatitis B and C
 
HEPATITIS.ppt
HEPATITIS.pptHEPATITIS.ppt
HEPATITIS.ppt
 
dysfunction of Liver system in body and the nursing intervention to the patient
dysfunction of Liver system in body and the nursing intervention to the patientdysfunction of Liver system in body and the nursing intervention to the patient
dysfunction of Liver system in body and the nursing intervention to the patient
 
HEPATITIS.ppt
HEPATITIS.pptHEPATITIS.ppt
HEPATITIS.ppt
 
Hepatitis in english
Hepatitis in englishHepatitis in english
Hepatitis in english
 
Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1Current managent of hepatitis B - Session 1
Current managent of hepatitis B - Session 1
 
Hepatitis B Department of Physiotherapy, SHUATS
Hepatitis B Department of Physiotherapy, SHUATSHepatitis B Department of Physiotherapy, SHUATS
Hepatitis B Department of Physiotherapy, SHUATS
 
HIV HEP C STD and Infectious Disease Training
HIV HEP C  STD and Infectious Disease TrainingHIV HEP C  STD and Infectious Disease Training
HIV HEP C STD and Infectious Disease Training
 
Hepatitis a
Hepatitis aHepatitis a
Hepatitis a
 
Viral hepatitis.pptx
Viral hepatitis.pptxViral hepatitis.pptx
Viral hepatitis.pptx
 

Dernier

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 

Dernier (20)

INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 

HBV (hepatitis B virus )

  • 1. -Omar Ali Saad Mansour -01151234525 -For any assignment or presentation No fees
  • 2. Definition Hepatitis B is an infectious disease caused by the hepatitis b virus (HBV) which affects the liver. It can cause both acute and chronic infection . Many people have no symptoms during the initial infection.
  • 3. The virus is transmitted by exposure to infectious blood or body fluids. infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, IV drug use and sexual intercourse are the most frequent routes of infection.
  • 4.
  • 5. High Moderate Low/Not Detectable blood semen urine serum vaginal fluid feces wound exudates saliva sweat tears breastmilk Concentration of Hepatitis B Virus in Various Body Fluids
  • 6. Signs and Symptoms ranging from mild to severe, usually appear about one to four months after you've been infected Signs and symptoms of hepatitis B may include: - Abdominal pain - Dark urine - Fever - Joint pain - Loss of appetite - Nausea and vomiting - Weakness and fatigue - Yellowing of your skin and the whites of your eyes (jaundice)
  • 7. Causes Hepatitis B infection is caused by the hepatitis B virus (HBV). The virus is passed from person to person through blood, semen or other body fluids. Common ways HBV is transmitted include: Sexual contact. You may become infected if you have unprotected sex with an infected partner whose blood, saliva, semen or vaginal secretions enter your body.
  • 8. Sharing of needles. HBV is easily transmitted through needles and syringes contaminated with infected blood. Sharing intravenous (IV) drug paraphernalia puts you at high risk of hepatitis B. Accidental needle sticks. Hepatitis B is a concern for health care workers and anyone else who comes in contact with human blood. Mother to child. Pregnant women infected with HBV can pass the virus to their babies during childbirth. However, the newborn can be vaccinated to avoid getting infected in almost all cases. Talk to your doctor about being tested for hepatitis B if you are pregnant or want to become pregnant.
  • 9. Mechanism The virus mainly affects liver function. It invades the liver cells (hepatocytes) and uses the cells’ machinery to replicate within it. The hepatitis B virion binds to the hepatocyte via the preS domain of the viral surface antigen. The cell then engulfs the virus in a process called endocytosis. As the infection occurs, the host immune response is triggered. The body’s immune system attacks the infected hepatocytes, which leads to liver injury at the same time as clearing the virus from the body.
  • 10. The liver damage associated with HBV infection is mainly caused by the adaptive immune response, particularly the virus- specific cytotoxic T lymphocytes (CTLs). These CTLs kill cells that contain the virus. Liver damage is also aggravated by the antigen-nonspecific inflammatory cells and activated platelets at the site of infection.
  • 11.
  • 12. Acute vs. chronic hepatitis B Hepatitis B infection may be either short-lived (acute) or long lasting (chronic). Acute hepatitis B infection lasts less than six months. Your immune system likely can clear acute hepatitis B from your body, and you should recover completely within a few months. Most people who acquire hepatitis B as adults have an acute infection, but it can lead to chronic infection.
  • 13. Chronic hepatitis B infection lasts six months or longer. When your immune system can't fight off the acute infection, hepatitis B infection may last a lifetime, possibly leading to serious illnesses such as cirrhosis and liver cancer. The younger you are when you get hepatitis B — particularly newborns or children younger than 5 — the higher your risk the infection becoming chronic. Chronic infection may go undetected for decades until a person becomes seriously ill from liver disease.
  • 14. Investigation A- serology : 1- HBsAg 2- antibody to HBsAg ( anti-HBs ) 3- HBcAg 4- antibody to HBcAg ( anti-HBc ) 5- HBeAg
  • 15. B- viral load : * HBV-DNA can be measured by PCR In the blood . * Measurement of viral load is important in monitoring antiviral therapy .
  • 17. prevention - Hepatitis B vaccine can prevent hepatitis B. - It is the first anti-cancer vaccine because it can prevent a form of liver cancer (hepatocarcinoma).
  • 18. Who should get hepatitis B vaccine and when? - Everyone 18 years of age and younger - Adults over 18 who are at risk
  • 19. Adults who are at risk for HBV infection - Household contacts of persons with chronic HBV infection - Sex contacts of infected people - People who have more than one sex partner in 6 months - People who inject illegal drugs - Heath care and public safety workers who might be exposed to infected blood or body fluids - Hemodialysis patients
  • 20. doses of hepatitis B vaccine * Infant whose mother is infected with HBV: - First Dose: within 12 hours of birth - Second Dose: 1 - 2 months of age - Third Dose: 6 months of age
  • 21. * Infant whose mother is NOT infected with HBV: - First Dose: between birth – 2 months of age - Second Dose: 1 - 4 months of age (at least 1 month after first dose) - Third Dose: 6 - 18 months of age (at least 2 months after the second dose)
  • 22. Emergency hepatitis B vaccination - In some situations, you may also need to have an injection of antibodies called specific hepatitis B immunoglobulin (HBIG) along with the hepatitis B vaccine. - HBIG should ideally be given within 48 hours, but you can still have it up to a week after exposure.
  • 23.
  • 24. Risks of hepatitis B vaccine - Severe allergic reactions, harm or death (extremely rare) - Soreness at site of injection lasting 1-2 days - Mild to moderate fever
  • 25. What if there is a moderate or severe reaction? What is an allergic reaction? - Hives, swelling, redness - High fever - Difficulty breathing, wheezing - Dizziness - Unusual behavior When to expect an allergic reaction? - Within a few minutes to a few hours after the shot What should I do? - CALL a doctor or see a doctor right away - TELL your doctor what happened, and when the vaccination was given
  • 26. precautions - A common set of infection-control strategies should be effective for preventing hepatitis B. MEDICAL HISTORY: Always obtain a thorough medical history. Include specific questions about medications, current illnesses, hepatitis.
  • 27. PROTECTIVE ATTIRE AND BARRIER TECHNIQUES For protection of personnel and patients: 1-when touching blood, saliva, or mucous membranes . Gloves must be worn when touching blood-soiled items, body fluids, or secretions, as well as surfaces contaminated with them. Gloves must be worn when examining all oral lesions. 2. Surgical masks and protective eyewear or face shields must be worn when splashing or spattering of blood or other body fluids is likely, as is common in dentistry. 3. Reusable or disposable gowns, laboratory coats, or uniforms must be worn when clothing is likely to be soiled with blood or other body fluids. 4. Impervious-backed paper or clear plastic wrap may be used to cover surfaces that may be contaminated by blood or saliva and that are difficult or impossible to disinfect. The coverings should be removed and replaced between patients. 5. All procedures and manipulations of potentially infective materials should be performed carefully to minimize the formation of droplets, spatters, and aerosols such as rubber dams.
  • 28.
  • 29. Hand washing Hands must always be washed between patient treatment contacts (following removal of gloves).
  • 30. CARE OF SHARP INSTRUMENTS AND NEEDLES 1-Sharp items (needles, scalpel blades, and other sharp instruments) should be considered as potentially infective and must be handled with extraordinary care to prevent unintentional injuries. 2. Disposable syringes and needles, scalpel blades, and other sharp items must be placed into puncture-resistant containers . 3. Recapping of a needle increases the risk of unintentional needlestick injury. One hand scope technique should be used . 4. A new (sterile) syringe and a fresh solution should be used for each patient.
  • 31.
  • 32. Epidemiology * Worldwide, HBV is the primary cause of liver cancer. - For males, it is the third leading cause of cancer mortality - For females, it is the sixth leading cause of cancer mortality
  • 33. - An estimated 800,000–1.4 million persons in the United States have chronic HBV infection. - Chronic infection is an even greater problem globally, affecting approximately 350 million persons. - An estimated 620,000 persons worldwide die from HBV-related liver disease each year. Hepatitis B
  • 34. -The incubation period from the time of exposure to onset of symptoms is 6 weeks to 6 months. - HBV is found in highest concentrations in blood and in lower concentrations in other body fluids (e.g., semen, vaginal secretions, and wound exudates). - HBV infection can be self-limited or chronic. Hepatitis B
  • 35. Hepatitis B In adults, only approximately half of newly acquired HBV infections are symptomatic, and approximately 1% of reported cases result in acute liver failure and death.
  • 36. Symptomatic Infection Chronic Infection Age at Infection Chronic Infection (%) SymptomaticInfection(%) Birth 1-6 months 7-12 months 1-4 years Older Children and Adults 0 20 40 60 80 100100 80 60 40 20 0 Outcome of Hepatitis B Virus Infection by Age at Infection ChronicInfection(%)
  • 37. Possible Outcomes of HBV Infection Acute hepatitis B infection Chronic HBV infection 3-5% of adult-acquired infections 95% of infant- acquired infections Cirrhosis Chronic hepatitis 12-25% in 5 years Liver failureHepatocellular carcinoma Liver transplant 6-15% in 5 years 20-23% in 5 years DeathDeath
  • 38. Complications Scarring of the liver (cirrhosis). The inflammation associated with a hepatitis B infection can lead to extensive liver scarring (cirrhosis), which may impair the liver's ability to function. Liver cancer. People with chronic hepatitis B infection have an increased risk of liver cancer. Liver failure. Acute liver failure is a condition in which the vital functions of the liver shut down. When that occurs, a liver transplant is necessary to sustain life. Other conditions. People with chronic hepatitis B may have kidney disease, inflammation of blood vessels or anemia.
  • 39. Treatment and Drugs Treatment to prevent hepatitis B infection after exposure If you know you've been exposed to the hepatitis B virus, call your doctor immediately. If you haven't been vaccinated or aren't sure whether you've been vaccinated or whether you responded to the vaccination, receiving an injection of hepatitis B immune globulin within 12 hours of coming in contact with the virus may help protect you from developing hepatitis B. You should be vaccinated at the same time.
  • 40. Treatment for acute hepatitis B infection If your doctor determines your hepatitis B infection is acute — meaning it is short-lived and will go away on its own — you may not need treatment. Instead, your doctor might recommend rest and adequate nutrition and fluids while your body fights the infection.
  • 41. If you've been diagnosed with chronic hepatitis B infection, you may have treatment to reduce the risk of liver disease and prevent you from passing the infection to others. Treatments include: Antiviral medications. Several antiviral medications — including lamivudine (Epivir), adefovir (Hepsera), telbivudine (Tyzeka) and entecavir (Baraclude) — can help fight the virus and slow its ability to damage your liver. Talk to your doctor about which medication might be right for you. Treatment for chronic hepatitis B infection
  • 42. Interferon alfa-2b (Intron A). This synthetic version of a substance produced by the body to fight infection is used mainly for young people with hepatitis B who don't want to undergo long-term treatment or who might want to get pregnant within a few years. It's given by injection. Side effects may include depression, difficulty breathing and chest tightness. Liver transplant. If your liver has been severely damaged, a liver transplant may be an option. During a liver transplant, the surgeon removes your damaged liver and replaces it with a healthy liver. Most transplanted livers come from deceased donors, though a small number come from living donors who donate a portion of their livers. Other drugs to treat hepatitis B are being developed.

Notes de l'éditeur

  1. Roger Detels - Epi 220 - 20 Feb 2014
  2. Roger Detels - Epi 220 - 20 Feb 2014
  3. Roger Detels - Epi 220 - 20 Feb 2014
  4. Roger Detels - Epi 220 - 20 Feb 2014